Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Evaluation of the agreement between TNM 7th and 8th in a population-based series of cutaneous melanoma.

Crocetti E, Stanganelli I, Mancini S, Vattiato R, Giuliani O, Ravaioli A, Balducci C, Falcini F, Pimpinelli N.

J Eur Acad Dermatol Venereol. 2018 Oct 13. doi: 10.1111/jdv.15285. [Epub ahead of print]

PMID:
30317667
2.

Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.

Lazzaretti MG, Ponti A, Mano MP, Barca A, Casella D, Frigerio A, Giordano L, Mantellini P, Paduos A, Pitarella S, Ravaioli A, Taffurelli M, Tomatis M, Segnan N.

Breast. 2018 Aug 14;42:15-22. doi: 10.1016/j.breast.2018.08.001. [Epub ahead of print]

PMID:
30138762
3.

Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.

Bucchi L, Baldacchini F, Mancini S, Ravaioli A, Giuliani O, Vattiato R, Falcini F, Giorgi Rossi P, Campari C, Canuti D, Di Felice E, Sassoli de Bianchi P, Ferretti S, Bertozzi N, Biggeri A; Emilia-Romagna Region Workgroup for Cervical Screening Evaluation.

Int J Cancer. 2018 Aug 18. doi: 10.1002/ijc.31806. [Epub ahead of print]

PMID:
30120770
4.

[Cancer and risk of suicide: follow-up and multidisciplinarity may offer opportunities for prevention.]

Ravaioli A, Bucchi L.

Recenti Prog Med. 2018 Jun;109(6):322-323. doi: 10.1701/2932.29485. Italian.

PMID:
29968859
5.

The Results of an Italian Quality Assurance Program Support the New American Society for Colposcopy and Cervical Pathology Recommendations for Colposcopy Practice.

Garutti P, Cristiani P, Ferretti S, Sassoli de Bianchi P, Ravaioli A, Bucchi L.

J Low Genit Tract Dis. 2018 Jul;22(3):235-236. doi: 10.1097/LGT.0000000000000403. No abstract available.

PMID:
29762429
6.

Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG).

Saragoni L, Scarpi E, Ravaioli A, Morgagni P, Roviello F, Vindigni C, Rausei S, Chiaravalli AM, Fumagalli U, Spaggiari P, Rosa F, Ricci R, Donini A, Giovenali P, Tomezzoli A, De Manzoni G.

Oncologist. 2018 Jul;23(7):852-858. doi: 10.1634/theoncologist.2017-0488. Epub 2018 Jan 31.

PMID:
29386311
7.

Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically.

Ravaioli A, Falcini F, Bucchi L.

Breast Cancer Res Treat. 2018 Feb;167(3):817-818. doi: 10.1007/s10549-017-4535-7. Epub 2017 Oct 13. No abstract available.

PMID:
29027616
8.

A model of an inflammatory bowel disease population-based registry: The Forlì experience (1993-2013).

Valpiani D, Manzi I, Mercuriali M, Giuliani O, Ravaioli A, Colamartini A, Bucchi L, Falcini F, Ricci E.

Dig Liver Dis. 2018 Jan;50(1):32-36. doi: 10.1016/j.dld.2017.09.120. Epub 2017 Sep 21.

PMID:
28988755
9.

Immigrants and cancer in Italy: a literature review.

Crocetti E, Giuliani O, Ravaioli A, Bucchi L, Vattiato R, Falcini F.

Ann Ist Super Sanita. 2017 Jul-Sep;53(3):238-245. doi: 10.4415/ANN_17_03_10. Review.

10.

Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116].

Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, Canuti D, Cirilli C, Collina N, Conti GM, Di Felice E, Falcini F, Michiara M, Negri R, Ravaioli A, Sassoli De' Bianchi P, Serafini M, Zorzi M, Caldarella A, Cataliotti L, Zappa M; IMPACT COHORT Working Group.

Eur J Cancer. 2017 Nov;85:160. doi: 10.1016/j.ejca.2017.08.016. Epub 2017 Sep 2. No abstract available.

PMID:
28870467
11.

Extension of the target age range of mammography screening programme and governance of mammography practice in the Emilia-Romagna Region (Northern Italy).

Sassoli de Bianchi P, Ravaioli A, Ferretti S, Finarelli AC, Giannini A, Naldoni C, Sanna P, Bucchi L.

Epidemiol Prev. 2017 Jan-Feb;41(1):38-45. doi: 10.19191/EP17.1.P038.010. Italian.

PMID:
28322527
12.

Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy.

Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, Canuti D, Cirilli C, Collina N, Conti GM, Di Felice E, Falcini F, Michiara M, Negri R, Ravaioli A, Sassoli De' Bianchi P, Serafini M, Zorzi M, Caldarella A, Cataliotti L, Zappa M; IMPACT COHORT Working Group.

Eur J Cancer. 2017 Apr;75:109-116. doi: 10.1016/j.ejca.2016.12.030. Epub 2017 Feb 20. Erratum in: Eur J Cancer. 2017 Nov;85:160.

PMID:
28222306
13.

Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.

Mancini S, Ravaioli A, Falcini F, Giuliani O, Corradini R, De Girolamo G, Goldoni CA, Finarelli AC, Naldoni C, Landi P, Sassoli de Bianchi P, Bucchi L.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12631. Epub 2016 Dec 29.

PMID:
28032381
14.

Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors.

Mancini S, Ravaioli A, Giuliani O, Vattiato R, Falcini F, Ferretti S, Costa S, Bucchi L.

Int J Cancer. 2017 Jan 1;140(1):247-248. doi: 10.1002/ijc.30435. Epub 2016 Oct 6. No abstract available.

15.

Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study.

Garutti P, Cristiani P, Fantin GP, Sopracordevole F, Costa S, Schincaglia P, Ravaioli A, Sassoli de Bianchi P, Naldoni C, Ferretti S, Bucchi L.

Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:64-69. doi: 10.1016/j.ejogrb.2016.08.037. Epub 2016 Aug 31.

PMID:
27639133
16.

The Relationship Between Gastric and Esophageal Cancers in Italy.

Crocetti E, Mancini S, Ravaioli A, Giuliani O, Bucchi L, Falcini F.

Am J Gastroenterol. 2016 Aug;111(8):1201-2. doi: 10.1038/ajg.2016.172. No abstract available.

PMID:
27481421
17.

Early (short-interval) rescreen in mammography screening.

Ravaioli A, Mancini S, Giuliani O, Vattiato R, Falcini F, Ferretti S, Bucchi L.

J Med Screen. 2017 Mar;24(1):54-55. doi: 10.1177/0969141316649406. Epub 2016 Jul 19. No abstract available.

PMID:
27430536
18.

Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors.

Giuliani O, Mancini S, Puliti D, Caranci N, Ravaioli A, Vattiato R, Palumbo M, Colamartini A, Biggeri A, Bucchi L, Amadori D, Falcini F.

Breast Cancer Res Treat. 2016 Aug;158(3):543-51. doi: 10.1007/s10549-016-3895-8. Epub 2016 Jul 8.

PMID:
27393619
19.

Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective.

Ravaioli A, Mancini S, Naldoni C, Falcini F, Ferretti S, Bucchi L.

Public Health. 2016 Jul;136:178-80. doi: 10.1016/j.puhe.2016.01.012. Epub 2016 Feb 23. No abstract available.

PMID:
26920857
20.

Gastric cancer incidence in the Romagna Region of Italy: A spatial and temporal analysis.

Mancini S, Ravaioli A, Giuliani O, Giorgetti S, Falcini F, Colamartini A, Bucchi L.

Dig Liver Dis. 2015 Dec;47(12):1076-81. doi: 10.1016/j.dld.2015.09.001. Epub 2015 Sep 25.

PMID:
26476476
21.

Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).

Bucchi L, Frigerio A, Zorzi M, Fedato C, Angiolucci G, Bernardi D, Campari C, Crocetti E, Ferretti S, Giorgi D, Marchisio F, Morrone D, Naldoni C, Petrella M, Ponti A, Ravaioli A, Saguatti G, Santini D, Sassoli de Bianchi P, Serafini M, Vergini V, Giordano L.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):52-7.

22.

Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy, 2011-2012.

Ponti A, Mano MP, Tomatis M, Baiocchi D, Barca A, Berti R, Casella D, D'Ambrosio E, Delos E, Donati G, Falcini F, Frammartino B, Frigerio A, Giudici F, Mantellini P, Naldoni C, Olla Atzeni C, Orzalesi L, Pagano G, Pietribiasi F, Pitarella S, Ravaioli A, Silvestri A, Taffurelli M, Tidone E, Zanconati F, Segnan N.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):40-7.

23.

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.

De Tursi M, Carella C, Tomao S, Cinieri S, Lorusso V, Marchetti P, Vecchio S, Sansoni E, Contu A, Adamo V, Silvestris N, Nuzzo A, Rosti G, Ravaioli A, Danova M, Tonini G, Passalacqua R, Cruciani G, Faedi M, Spada M, De Laurentiis M, Amoroso D, Tomao F, Sperduti I, Grassadonia A, Tinari N, Natoli C, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia.

Tumori. 2014 Nov-Dec;100(6):e309-13. doi: 10.1700/1778.19310. Erratum in: Tumori. 2015 Nov-Dec;101(6):704.

PMID:
25688518
24.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, Comella G, Amadori D, Pinto C, Carlomagno C, Nitti D, Daniele B, Mini E, Poli D, Santoro A, Mosconi S, Casaretti R, Boni C, Pinotti G, Bidoli P, Landi L, Rosati G, Ravaioli A, Cantore M, Di Fabio F, Aitini E, Marchet A; ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group.

Ann Oncol. 2014 Jul;25(7):1373-8. doi: 10.1093/annonc/mdu146. Epub 2014 Apr 12.

PMID:
24728035
25.

Estimates of cancer burden in Emilia-Romagna.

Falcini F, Mancini S, Ravaioli A, Vattiato R, Bucchi L, Ferretti S, Michiara M, Federico M, Ponz de Leon M, Mangone L, Rossi S, Foschi R.

Tumori. 2013 May-Jun;99(3):327-33. doi: 10.1700/1334.14796.

PMID:
24158061
26.

Prediction of nodal metastasis and prognosis of breast cancer by ANN-based assessment of tumour size and p53, Ki-67 and steroid receptor expression.

Mojarad S, Venturini B, Fulgenzi P, Papaleo R, Brisigotti M, Monti F, Canuti D, Ravaioli A, Woo L, Dlay S, Sherbet GV.

Anticancer Res. 2013 Sep;33(9):3925-33.

PMID:
24023330
27.

Coexistence of EGFR mutation and ALK translocation in NSCLC: literature review and case report of response to gefitinib.

Santelmo C, Ravaioli A, Barzotti E, Papi M, Poggi B, Drudi F, Mangianti M, Salvi M, Crinò L.

Lung Cancer. 2013 Aug;81(2):294-6. doi: 10.1016/j.lungcan.2013.04.009. Epub 2013 May 14.

PMID:
23683537
28.

[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].

Drudi F, Tassinari D, Giuliani J, Ridolfi C, Gianni L, Tamburini E, Fantini M, Santelmo C, Barzotti E, Lotti N, Ravaioli A.

Recenti Prog Med. 2013 Feb;104(2):80-5. doi: 10.1701/1241.13711. Review. Italian.

PMID:
23535964
29.

Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report.

Ridolfi C, Pasini G, Drudi F, Barzotti E, Santelmo C, Polselli A, Ravaioli A.

J Med Case Rep. 2013 Jan 24;7:29. doi: 10.1186/1752-1947-7-29.

30.

[Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010].

Ponti A, Mano MP, Tomatis M, Baiocchi D, Barca A, Berti R, Bisanti L, Casella D, Deandrea S, Delrio D, Donati G, Falcini F, Frammartino B, Frigerio A, Mantellini P, Naldoni C, Orzalesi L, Pagano G, Pietribiasi F, Ravaioli A, Sedda ML, Taffurelli M, Cataliotti L, Segnan N.

Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):87-95. Italian.

31.

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C.

J Thorac Oncol. 2012 Dec;7(12):1830-1844. doi: 10.1097/JTO.0b013e318275b327.

32.

Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.

Imola M, Mianulli AM, Pasini G, Santelmo C, Drudi F, Fantini M, Corso V, Veneroni L, Ravaioli A.

G Chir. 2012 Mar;33(3):74-6.

PMID:
22525550
33.

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.

Guarneri V, Frassoldati A, Bottini A, Cagossi K, Bisagni G, Sarti S, Ravaioli A, Cavanna L, Giardina G, Musolino A, Untch M, Orlando L, Artioli F, Boni C, Generali DG, Serra P, Bagnalasta M, Marini L, Piacentini F, D'Amico R, Conte P.

J Clin Oncol. 2012 Jun 1;30(16):1989-95. doi: 10.1200/JCO.2011.39.0823. Epub 2012 Apr 9.

PMID:
22493419
34.

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study.

Pestrin M, Bessi S, Puglisi F, Minisini AM, Masci G, Battelli N, Ravaioli A, Gianni L, Di Marsico R, Tondini C, Gori S, Coombes CR, Stebbing J, Biganzoli L, Buyse M, Di Leo A.

Breast Cancer Res Treat. 2012 Jul;134(1):283-9. doi: 10.1007/s10549-012-2045-1. Epub 2012 Apr 4.

PMID:
22476856
35.

Lipoplatin treatment in lung and breast cancer.

Fantini M, Gianni L, Santelmo C, Drudi F, Castellani C, Affatato A, Nicolini M, Ravaioli A.

Chemother Res Pract. 2011;2011:125192. doi: 10.1155/2011/125192. Epub 2010 Dec 21.

36.

Audit on quality of breast cancer diagnosis and treatment in Italy, 2008-2009.

Ponti A, Tomatis M, Baiocchi D, Barca A, Berti R, Bisanti L, Bordon R, Casella D, Cogo C, Deandrea S, Delrio D, Donati G, Falcini F, Frigerio A, Leonardo N, Mancini S, Mantellini P, Naldoni C, Pagano G, Ravaioli A, Pietribiasi F, Sedda ML, Taffurelli M, Zorzi M, Cataliotti L, Segnan N, Mano MP.

Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 5):87-95. English, Italian.

37.

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.

Pignata S, Scambia G, Ferrandina G, Savarese A, Sorio R, Breda E, Gebbia V, Musso P, Frigerio L, Del Medico P, Lombardi AV, Febbraro A, Scollo P, Ferro A, Tamberi S, Brandes A, Ravaioli A, Valerio MR, Aitini E, Natale D, Scaltriti L, Greggi S, Pisano C, Lorusso D, Salutari V, Legge F, Di Maio M, Morabito A, Gallo C, Perrone F.

J Clin Oncol. 2011 Sep 20;29(27):3628-35. doi: 10.1200/JCO.2010.33.8566. Epub 2011 Aug 15.

PMID:
21844495
38.

Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy, 2007.

Mano MP, Ponti A, Tomatis M, Baiocchi D, Barca A, Berti R, Bordon R, Casella D, Delrio D, Donati G, Falcini F, Frigerio A, Furini A, Mantellini P, Naldoni C, Pagano G, Piccini P, Ravaioli A, Rodella D, Sapino A, Sedda ML, Taffurelli M, Vettorazzi M, Zorzi M, Cataliotti L, Segnan N.

Epidemiol Prev. 2010 Sep-Dec;34(5-6 Suppl 4):81-8.

39.

Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.

Fantini M, Gianni L, Tassinari D, Nicoletti S, Possenti C, Drudi F, Sintini M, Bagli L, Tamburini E, Ravaioli A.

J Oncol Pharm Pract. 2011 Sep;17(3):288-91. doi: 10.1177/1078155210374891. Epub 2010 Oct 6. Review.

PMID:
20926454
40.

Small cell neuroendocrine tumor of the breast in a 40 year-old woman: a case report.

Nicoletti S, Papi M, Drudi F, Fantini M, Canuti D, Tamburini E, Possenti C, Pasquini E, Brisigotti M, Ravaioli A.

J Med Case Rep. 2010 Jun 30;4:201. doi: 10.1186/1752-1947-4-201.

41.

Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients.

De Portu S, Mantovani LG, Ravaioli A, Tamburini E, Bollina R, Cozzi C, Grimaldi AM, Testa TE, Bianchessi C, Carteni G.

J Chemother. 2010 Apr;22(2):125-8.

PMID:
20435573
42.

Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.

Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C, Finarelli AC, de Bianchi PS, Bucchi L.

BMC Med. 2010 Feb 1;8:11. doi: 10.1186/1741-7015-8-11.

43.

Trastuzumab-related thrombocytopenia: always a self-limiting complication?

Drudi F, Gianni L, Fantini M, Ravaioli A.

Ann Oncol. 2010 Mar;21(3):668-9. doi: 10.1093/annonc/mdp566. Epub 2009 Dec 23. No abstract available.

PMID:
20032121
44.

Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy for 2006 and preliminary results for 2007.

Tomatis M, Mano MP, Baiocchi D, Barca A, Bordon R, Casella D, Donati G, Berti R, Filippini L, Frigerio A, Furini A, Mantellini P, Naldoni C, Pagano G, Ramera D, Ravaioli A, Sapino A, Taffurelli M, Vettorazzi M, Zorzi M, Cataliotti L, Rosselli Del Turco M, Segnan N, Ponti A.

Epidemiol Prev. 2009 May-Jun;33(3 Suppl 2):83-90.

45.

Liver resection of colorectal metastases and adjuvant chemotherapy: can published data really support clinicians in clinical practice?

Tamburini E, Tassinari D, Nicoletti S, Ravaioli A.

Clin Oncol (R Coll Radiol). 2010 Feb;22(1):84-5. doi: 10.1016/j.clon.2009.09.027. Epub 2009 Oct 27. No abstract available.

PMID:
19864119
46.

[Estimating standard performance measures of opportunistic screening for prostate cancer].

Leoni M, Falcini F, Ravaioli A, Foca F, Andalò G, Benini F, Dal Pozzo C, Ricci R, Naldoni C, Bucchi L.

Epidemiol Prev. 2008 Nov-Dec;32(6):285-93. Italian.

47.

[Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].

Tassinari D, Tamburini E, Carloni F, Nicoletti S, Ravaioli A.

Recenti Prog Med. 2009 Feb;100(2):73-9. Italian.

PMID:
19350798
48.

Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancer.

Ravaioli A, Papi M, Pasquini E, Marangolo M, Rudnas B, Fantini M, Nicoletti SV, Drudi F, Panzini I, Tamburini E, Gianni L, Pasini G.

J Chemother. 2009 Feb;21(1):86-90.

PMID:
19297279
49.

Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.

Sun Z, Goldhirsch A, Price KN, Colleoni M, Ravaioli A, Simoncini E, Campbell I, Gelber RD, Towler M.

Breast. 2009 Apr;18(2):84-8. doi: 10.1016/j.breast.2009.01.003. Epub 2009 Feb 24.

50.

Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer.

Calistri D, Rengucci C, Molinari C, Ricci E, Cavargini E, Scarpi E, Milandri GL, Fabbri C, Ravaioli A, Russo A, Amadori D, Silvestrini R.

Cell Oncol. 2009;31(1):11-7.

Supplemental Content

Loading ...
Support Center